AWS Launches Amazon Bio Discovery to Turbocharge AI Drug Discovery

AWS Makes Its Boldest Move Into Drug Discovery

Amazon Web Services has launched Amazon Bio Discovery, an artificial intelligence application designed to dramatically accelerate early-stage drug discovery. Announced at the company's annual Life Sciences Symposium at the Javits Center in New York, the platform represents AWS's most significant step yet beyond cloud infrastructure and into the drug discovery application layer.

How It Works

At the heart of the platform is what AWS calls a "lab-in-the-loop" workflow. Researchers use AI agents to design computational experiments, generate and rank drug candidates, and then route the most promising molecules directly to integrated laboratory partners, including Ginkgo Bioworks, Twist Bioscience, and A-Alpha Bio, for physical synthesis and testing. When lab results return, they feed automatically back into the platform, allowing models to be refined on proprietary data for the next cycle.

The platform provides access to more than forty biological foundation models trained on vast biological datasets, all within a no-code environment. This means computational biologists can build reusable workflow templates, whilst bench scientists can configure and launch experiments independently using AI agent guidance.

Real-World Results

AWS highlighted a collaboration with Memorial Sloan Kettering Cancer Center as a key proof point. Using Amazon Bio Discovery, MSK researchers designed nearly three hundred thousand novel antibody candidates, filtered them to the top one hundred thousand, and sent them for wet-lab testing, a process that took weeks rather than up to a year using traditional methods. The work focused on potential paediatric cancer therapies.

Growing Ecosystem

Bayer, the Broad Institute, and Voyager Therapeutics are among early adopters. AWS also announced a collaboration with Flagship Pioneering to support AI-native drug discovery startups. Nineteen of the top twenty global pharmaceutical companies already use AWS cloud services. The platform is available immediately, with a free trial offering five experimental units before subscription tiers are introduced.